Literature DB >> 8290744

The host inflammatory response prior to death in patients with cystic fibrosis and chronic Pseudomonas aeruginosa infection.

J S Elborn1, S M Cordon, D Parker, F M Delamere, D J Shale.   

Abstract

The intensity of the host inflammatory response to pulmonary infection with Pseudomonas aeruginosa immediately prior to death was determined in six patients with cystic fibrosis (CF). Plasma concentrations of neutrophil elastase alpha 1-antiproteinase, tumour necrosis factor-alpha (TNF alpha) and serum C-reactive protein (CRP) were increased in the 7 days prior to death (P < 0.05) when compared with a period of clinical stability during the preceding 6 months. An increased inflammatory response was sustained for many weeks prior to death and was associated with poor symptom and lung function responses to apparently appropriate antibiotic treatment.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8290744     DOI: 10.1016/s0954-6111(05)80263-x

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  7 in total

1.  Nutrition and survival in cystic fibrosis.

Authors:  J S Elborn; S C Bell
Journal:  Thorax       Date:  1996-10       Impact factor: 9.139

2.  Cytokines and inflammatory mediators do not indicate acute infection in cystic fibrosis.

Authors:  J M Wolter; R L Rodwell; S D Bowler; J G McCormack
Journal:  Clin Diagn Lab Immunol       Date:  1999-03

Review 3.  Monitoring inflammation in CF. Cytokines.

Authors:  Scott D Sagel; Frank J Accurso
Journal:  Clin Rev Allergy Immunol       Date:  2002-08       Impact factor: 8.667

4.  Short Palate, Lung, and Nasal Epithelial Clone 1 Has Antimicrobial and Antibiofilm Activities against the Burkholderia cepacia Complex.

Authors:  Saira Ahmad; Jean Tyrrell; William G Walton; Ashutosh Tripathy; Matthew R Redinbo; Robert Tarran
Journal:  Antimicrob Agents Chemother       Date:  2016-09-23       Impact factor: 5.191

5.  Clinical utility of C-reactive protein to predict treatment response during cystic fibrosis pulmonary exacerbations.

Authors:  Ashutosh Sharma; Gordon Kirkpatrick; Virginia Chen; Kate Skolnik; Zsuzsanna Hollander; Pearce Wilcox; Bradley S Quon
Journal:  PLoS One       Date:  2017-02-08       Impact factor: 3.240

6.  Myeloperoxidase and eosinophil cationic protein in serum and sputum during antibiotic treatment in cystic fibrosis patients with Pseudomonas aeruginosa infection.

Authors:  B Niggemann; T Stiller; K Magdorf; U Wahn
Journal:  Mediators Inflamm       Date:  1995       Impact factor: 4.711

7.  Role of C-reactive protein as a biomarker for prediction of the severity of pulmonary exacerbations in patients with cystic fibrosis.

Authors:  Rosa Maria Girón-Moreno; José L Justicia; Sara Yamamoto; Claudia Valenzuela; Carolina Cisneros; Rosa Mar Gómez-Punter; Gilda Fernandes-Vasconcelos; Julio Ancochea
Journal:  BMC Pulm Med       Date:  2014-09-23       Impact factor: 3.317

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.